Episode
How Amicus Embedded Patient Advocacy into its Corporate DNA
- Podcast
- PharmaTalkRadio
- Published
- Jan 29, 2026
- Duration seconds
- 1517
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/how-amicus-embedded-patient-advocacy-into-its-corporate-dna/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/pharmatalkradio-7131046/how-amicus-embedded-patient-advocacy-into-its-corporate-dna.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
About this podcast: In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact. More specifically, Ms Gershkowitz focuses on: Defining role standards and recruiting the right talent Co-creatin research with patient communities and developing patient-centered outcomes Generating metrics that demonstrate the impact on R&D